Pundavela J, Hall A, Dinglasan S, Choi K, Rizvi T, Trapnell B
Cancers (Basel). 2025; 17(5).
PMID: 40075752
PMC: 11899227.
DOI: 10.3390/cancers17050905.
Pundavela J, Dinglasan S, Touvron M, Hummel S, Hu L, Rizvi T
Sci Adv. 2024; 10(42):eado6342.
PMID: 39413183
PMC: 11482331.
DOI: 10.1126/sciadv.ado6342.
White E, Rhodes S
Cancers (Basel). 2024; 16(5).
PMID: 38473354
PMC: 10930863.
DOI: 10.3390/cancers16050994.
Furnari F, Anastasaki C, Bian S, Fine H, Koga T, Le L
Dis Model Mech. 2024; 17(2).
PMID: 38353122
PMC: 10886724.
DOI: 10.1242/dmm.050533.
Lakes Y, Moye S, Mo J, Tegtmeyer M, Nehme R, Charlton M
Cell Rep Med. 2023; 4(12):101309.
PMID: 38086379
PMC: 10772348.
DOI: 10.1016/j.xcrm.2023.101309.
Identification of an Microdeletion with Optical Genome Mapping.
Buki G, Beko A, Bodor C, Urban P, Nemeth K, Hadzsiev K
Int J Mol Sci. 2023; 24(17).
PMID: 37686382
PMC: 10487413.
DOI: 10.3390/ijms241713580.
Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.
Larsson A, Bhatia H, Calizo A, Pollard K, Zhang X, Conniff E
Neuro Oncol. 2023; 25(11):2044-2057.
PMID: 37246765
PMC: 10628938.
DOI: 10.1093/neuonc/noad097.
Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and response to MEK inhibitor.
Jiang C, Kumar A, Yu Z, Shipman T, Wang Y, McKay R
J Clin Invest. 2023; 133(12).
PMID: 37140985
PMC: 10266775.
DOI: 10.1172/JCI168227.
A physical perspective to understand myelin II: The physical origin of myelin development.
Liu Y, Yue W, Yu S, Zhou T, Zhang Y, Zhu R
Front Neurosci. 2022; 16:951998.
PMID: 36263368
PMC: 9574017.
DOI: 10.3389/fnins.2022.951998.
Neurofibroma Development in Neurofibromatosis Type 1: Insights from Cellular Origin and Schwann Cell Lineage Development.
Ge L, Xing M, Zhang H, Wang Z
Cancers (Basel). 2022; 14(18).
PMID: 36139671
PMC: 9497298.
DOI: 10.3390/cancers14184513.
Multiple Nf1 Schwann cell populations reprogram the plexiform neurofibroma tumor microenvironment.
Kershner L, Choi K, Wu J, Zhang X, Perrino M, Salomonis N
JCI Insight. 2022; 7(18.
PMID: 36134665
PMC: 9675562.
DOI: 10.1172/jci.insight.154513.
P2RY14 cAMP signaling regulates Schwann cell precursor self-renewal, proliferation, and nerve tumor initiation in a mouse model of neurofibromatosis.
Patritti Cram J, Wu J, Coover R, Rizvi T, Chaney K, Ravindran R
Elife. 2022; 11.
PMID: 35311647
PMC: 8959601.
DOI: 10.7554/eLife.73511.
Detection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis using aneuploidy and mutation identification in plasma.
Mattox A, Douville C, Silliman N, Ptak J, Dobbyn L, Schaefer J
Elife. 2022; 11.
PMID: 35244537
PMC: 9094745.
DOI: 10.7554/eLife.74238.
Malignant Peripheral Nerve Sheath Tumor Presenting as Horner's Syndrome.
Azharudeen Jr M, Selvaraj J, Pillai V, Meyyappan J, Veeranki V
Cureus. 2021; 13(9):e18341.
PMID: 34722092
PMC: 8551934.
DOI: 10.7759/cureus.18341.
Insights into the Pathogenesis of NF1-Associated Neoplasms.
Bui A, Jiang C, McKay R, Klesse L, Le L
JID Innov. 2021; 1(3).
PMID: 34604833
PMC: 8486282.
DOI: 10.1016/j.xjidi.2021.100044.
Tumorigenesis in neurofibromatosis type 1: role of the microenvironment.
Jiang C, McKay R, Le L
Oncogene. 2021; 40(39):5781-5787.
PMID: 34345017
PMC: 8713356.
DOI: 10.1038/s41388-021-01979-z.
Genotype-phenotype correlation in neurofibromatosis type-1: NF1 whole gene deletions lead to high tumor-burden and increased tumor-growth.
Well L, Dobel K, Kluwe L, Bannas P, Farschtschi S, Adam G
PLoS Genet. 2021; 17(5):e1009517.
PMID: 33951044
PMC: 8099117.
DOI: 10.1371/journal.pgen.1009517.
Increased nuclear translation of YAP might act as a potential therapeutic target for NF1-related plexiform neurofibroma.
Liu J, You Y, Tian Z, Xiao M, Zheng J, Wang Y
Int J Med Sci. 2021; 18(9):2008-2016.
PMID: 33850471
PMC: 8040406.
DOI: 10.7150/ijms.52431.
Spontaneous and Engineered Large Animal Models of Neurofibromatosis Type 1.
Osum S, Watson A, Largaespada D
Int J Mol Sci. 2021; 22(4).
PMID: 33669386
PMC: 7920315.
DOI: 10.3390/ijms22041954.
MicroRNA-155 contributes to plexiform neurofibroma growth downstream of MEK.
Na Y, Hall A, Choi K, Hu L, Rose J, Coover R
Oncogene. 2020; 40(5):951-963.
PMID: 33293695
PMC: 7867646.
DOI: 10.1038/s41388-020-01581-9.